ORLANCE, INC

Medtech · Private

Gene gun device that delivers DNA/RNA vaccine-coated gold microparticles into skin epidermis via needle-free microinjection

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $14.5M

Federal grants: $14.5M; 22 awards · 2018–2025; Rank in peer group#141 of 445
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 2 pending

Capital timeline

Latest events

Sep 2025Federal grantHealth and Human S · Phase I · Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals$300K
Aug 2025Federal grantHealth and Human S · Phase II · Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$977K
Apr 2025Federal grantHealth and Human S · Phase I · Gene Gun-delivered RNA vaccines.$300K
Aug 2024Federal grantHealth and Human S · Phase II · Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$990K
Aug 2024Federal grantHealth and Human S · Phase II · Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens$300K
Aug 2024Federal grantHealth and Human S · Phase I · Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.$200K
May 2024Federal grantHealth and Human S · Phase I · Gene Gun-delivered RNA vaccines.$300K

Show 15 earlier federal awards

Apr 2024Federal grantHealth and Human S · Phase II · Universal Influenza A/B Vaccine$1M
Sep 2023Federal grantHealth and Human S · Phase I · Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.$200K
Aug 2023Federal grantHealth and Human S · Phase II · Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$997K
May 2023Federal grantHealth and Human S · Phase II · Universal Influenza A/B Vaccine$999K
May 2022Federal grantHealth and Human S · Phase II · Universal Influenza A/B Vaccine$1M
May 2021Federal grantHealth and Human S · Phase II · Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics$955K
Apr 2021Federal grantHealth and Human S · Phase II · DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1M
Aug 2020Federal grantHealth and Human S · Phase II · Universal Influenza A/B Vaccine$300K
Jun 2020Federal grantHealth and Human S · Phase II · Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics$909K
Apr 2020Federal grantHealth and Human S · Phase II · DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1M
Aug 2019Federal grantHealth and Human S · Phase II · Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine$570K
Aug 2019Federal grantHealth and Human S · Phase II · DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1M
Mar 2019Federal grantHealth and Human S · Phase I · Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$299K
Apr 2018Federal grantHealth and Human S · Phase I · Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$599K
Apr 2018Federal grantHealth and Human S · Phase I · Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

Federal grants#141 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 2

PendingMedical Delivery DeviceUSPTOApplication PCTUS2022011672
PendingMedical Delivery DeviceUSPTOApplication 63135616

TAURUS DIAGNOSTICS, INCSimilar federal contract value in Medtech · null in contracts
LAP IQ, INC.Similar federal contract value in Medtech · null in contracts
Nano Composite Products, IncSimilar federal contract value in Medtech · null in contracts
IN VIVO ANALYTICS, INC.Similar federal contract value in Medtech · null in contracts
Pioneer Neurotech Inc.Similar federal contract value in Medtech · null in contracts
PRECISION DISCOVERY LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.